Community water fluoridation programs: a health technology assessment - review of dental caries and other health outcomes
CADTH
Record ID 32018002223
English
Original Title:
Community water fluoridation programs: a health technology assessment
Authors' objectives:
Note: 2020 update available: https://cadth.ca/community-water-fluoridation-exposure-review-neurological-and-cognitive-effects-2020-update
Community water fluoridation (CWF) is the controlled addition of fluoride to the public water supply with the aim of preventing cavities (i.e., dental caries) in the population. The practice of CWF has been subject to persistent concerns and controversy, which then influence discussions and decisions around both the adoption and the discontinuation of such programs in Canada and elsewhere. Specifically, there are concerns that CWF is linked to serious adverse health effects in those who drink the fluoridated water. There are signs that the uptake of CWF may be decreasing, as several large Canadian cities have recently stopped fluoridating their municipal water.
CADTH undertook a Health Technology Assessment to assess the effectiveness, cost considerations, and safety of CWF programs. Ethical issues, implementation considerations, and the potential environmental impact were also assessed.
Details
Project Status:
Completed
URL for project:
https://cadth.ca/community-water-fluoridation-programs-health-technology-assessment
URL for protocol:
https://cadth.ca/sites/default/files/pdf/HT0022-Community%20Water%20Fluoridation_Protocol.pdf
Year Published:
2019
URL for published report:
https://cadth.ca/sites/default/files/pdf/HT0022%20CWF%20-%20Clinical%20report.pdf
URL for additional information:
https://cadth.ca/community-water-fluoridation-programs-health-technology-assessment
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Canada
MeSH Terms
- Fluoridation
- Drinking Water
- Dental Caries
- Public Health
Keywords
- Fluoridation
- Public health
- Dental caries
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.